Table 3.
Strongyle fecal egg counts and percent reduction with 95% credible intervals (CI) in three groups of yearling Thoroughbreds imported from Ireland following either an oral administration of a triple combination (T) consisting of moxidectin (400 μg/kg), pyrantel pamoate (6.6 mg/kg) and oxibendazole (10 mg/kg) or a single dose of moxidectin (M, 400 μg/kg).
| N | Pre-treatment EPG |
Post-treatment EPG |
FECR (95% CI) | |||
|---|---|---|---|---|---|---|
| Mean | Range | Mean | Range | |||
| Group 4 | ||||||
| Ta | 2 | 336.0 | 320–350 | 0 | - | 100% (76.2–100) |
| Ma |
5 |
80.0 |
10–160 |
5.0 |
0–20 |
90.2% (62.6–98.2) |
| Group 5 | ||||||
| Ta | 9 | 313.3 | 20–760 | 0 | - | 100% (98.6–100) |
| Ma |
7 |
385.7 |
180–720 |
250.0 |
20–760 |
57.3% (26.1–78.6) |
| Group 6 | ||||||
| Mb | 16 | 1229.4 | 570–2060 | 638.8 | 180–1180 | 50.0% (30.7–64.2) |
a
Treatments administered on April 10, 2020.
b
Treatment administered on November 25, 2019.